We are live on ! Find out more
ARGS

Argos Therapeutics, Inc.
ARGS

Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

25 hedge funds and large institutions have $9.3M invested in Argos Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

4% less funds holding

Funds holding: 26 → 25 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

58% less capital invested

Capital invested by funds: $22M → $9.3M (-$12.7M)

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PSI
Pinnacle Summer Investments
Virginia
+$264K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$246K
3
Renaissance Technologies
Renaissance Technologies
New York
+$151K
4
SIM
Spark Investment Management
New York
+$145K
5
BFA
BlackRock Fund Advisors
California
+$75.5K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$3.49M
2
CS
Credit Suisse
Switzerland
-$154K
3
WA
Wasatch Advisors
Utah
-$95.2K
4
TRCT
Tower Research Capital (TRC)
New York
-$23K
5
SIP
Stoneridge Investment Partners
Pennsylvania
-$14.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$5.26M -$95.2K -1,126 -1%
Caisse de Depot et Placement du Quebec (CDPQ)
2
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$734K – – –
WSA
3
Wall Street Associates
California
$596K – – –
AGA
4
Altrinsic Global Advisors
Connecticut
$491K – – –
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$467K +$246K +2,906 +40%
Vanguard Group
6
Vanguard Group
Pennsylvania
$380K +$31.3K +370 +5%
PSI
7
Pinnacle Summer Investments
Virginia
$354K +$264K +3,125 +69%
Ohio Public Employees Retirement System (OPERS)
8
Ohio Public Employees Retirement System (OPERS)
Ohio
$180K – – –
FG
9
Formula Growth
Quebec, Canada
$162K +$296K +3,500 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$104K +$508 +6 +0.3%
BCM
11
Bridgeway Capital Management
Texas
$92K – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$82K +$151K +1,780 New
SIM
13
Spark Investment Management
New York
$79K +$145K +1,718 New
BFA
14
BlackRock Fund Advisors
California
$72K +$75.5K +892 +134%
HighTower Advisors
15
HighTower Advisors
Illinois
$60K – – –
SIP
16
Stoneridge Investment Partners
Pennsylvania
$55K -$14.3K -169 -13%
KeyBank National Association
17
KeyBank National Association
Ohio
$55K – – –
AIG
18
American International Group
New York
$27K +$25.9K +306 +111%
Northern Trust
19
Northern Trust
Illinois
$26K – – –
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$20K – – –
BIM
21
BlackRock Investment Management
Delaware
$4K +$677 +8 +10%
First Manhattan
22
First Manhattan
New York
$2K – – –
Bank of America
23
Bank of America
North Carolina
$1K – – –
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$1K – – –
AIC
25
AWM Investment Company
New York
– -$3.49M -35,965 Closed
1
2

ARGS Hedge Fund Activity: Q4 2015 in Review

25 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Argos Therapeutics, Inc. (ARGS) for Q4 2015, worth a combined $9.3M — down 58% from $22M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ARGS and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.

The largest buyer was Pinnacle Summer Investments, adding an estimated $264K. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.49M sold.

  • 25 institutional investors held Argos Therapeutics, Inc. (ARGS) as of Q4 2015, down from 26 in Q3 2015.
  • Funds reported $9.3M of Argos Therapeutics, Inc. stock for Q4 2015, down 58% quarter-over-quarter.
  • 4 funds opened new Argos Therapeutics, Inc. positions in Q4 2015 and 5 closed out, a net change of -1 holder.
  • The largest Argos Therapeutics, Inc. buyer in Q4 2015 was Pinnacle Summer Investments, an estimated $264K added.
  • The largest Argos Therapeutics, Inc. seller in Q4 2015 was AWM Investment Company, an estimated $3.49M sold.

Based on aggregated 13F filings for Q4 2015.